Purified human papillomavirus type 33 (HPV-33) peptides as an immunogenic composition
US5876723A · kind A · utility
14Cited by
11References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 15, 1997 |
| Grant date | Mar 2, 1999 |
| Priority date | — |
| Expiry date | Jul 15, 2017 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2710/20022
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention concerns DNA fragments derived from the genomic DNA of HPV-33. These fragments are selected from the group of fragments extending between the nucleotide extremities defined hereafter in relation to the nucleotide-numbering in FIGS. 1a and 1b respectively PA1 76-556 PA1 543-864 PA1 867-2811 PA1 2728-3808 PA1 3326-3575 PA1 3842-4079 PA1 4198-5611 PA1 5516-8091. The invention also relates to the use of these fragments as probes for the detection of HPV in tissue cultures.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.